FDA Approvals - Proton Pump Inhibitors Should Have Black-box Warnings, Group Tell FDAWithdrawal
Proton Pump Inhibitors Should Have Black-box Warnings, Group Tell FDA
Withdrawal from PPIs (proton pump inhibitors) can lead to severe rebound acid secretion, a complication that can force users to become dependent on them - this should be mentioned in a black-box warning, consumer group Public Citizen has told the FDA (Food and Drug Administration). Examples of PPIs include, Dexilant, Vimovo, Prilosec OTC, Prevacid 24-Hr, Zegerid, Zegerid OTC, Prevacid, Nexium ...